Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid PDF full book. Access full book title Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid by United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee. Download full books in PDF and EPUB format.

Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid

Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid PDF Author: United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 344

Book Description

Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid

Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid PDF Author: United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 344

Book Description

Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid

Problems with FDA's Regulation of the Antiarrhythmic Drugs Tambocor and Enkaid PDF Author: United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 332

Book Description

Legislative Reorganization Act of 1994

Legislative Reorganization Act of 1994 PDF Author: United States. Congress. House. Committee on Rules. Subcommittee on the Legislative Process
Publisher:
ISBN:
Category : Budget
Languages : en
Pages : 564

Book Description

Legislative Reorganization Act of 1994

Legislative Reorganization Act of 1994 PDF Author: United States. Congress. House. Committee on Rules. Subcommittee on the Legislative Process
Publisher:
ISBN:
Category : Budget
Languages : en
Pages : 572

Book Description

Monthly Catalog of United States Government Publications

Monthly Catalog of United States Government Publications PDF Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1528

Book Description

Monthly Catalogue, United States Public Documents

Monthly Catalogue, United States Public Documents PDF Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 752

Book Description

Legislative Calendar

Legislative Calendar PDF Author: United States. Congress. House. Committee on Government Operations
Publisher:
ISBN:
Category : Calendars
Languages : en
Pages : 316

Book Description

CIS Annual

CIS Annual PDF Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 1030

Book Description

CIS Index to Publications of the United States Congress

CIS Index to Publications of the United States Congress PDF Author: Congressional Information Service
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 1032

Book Description

Deadly Medicine

Deadly Medicine PDF Author: Thomas J. Moore
Publisher:
ISBN:
Category : Current Events
Languages : en
Pages : 360

Book Description
"Deadly Medicine tells the dramatic story of a great tragedy involving a class of drugs still on the market. It reveals why the same medical system that brings us lifesaving treatments can create a catastrophe almost beyond imagining." "The story begins with a new heart drug created in the research laboratories of the 3M Company. In animals, this drug appears unusually effective in suppressing irregular heartbeats. Hoping for a blockbuster, 3M launches clinical tests in humans and plans how to seize the market from competing companies. But as medical researchers test Tambocor, as the drug is called, the first signs of potential trouble appear. At Stanford University, a doctor warns that this type of powerful drug may be dangerous. Other experiments fail to demonstrate the expected benefits of such drugs. But with the support of their clinical doctors and with millions of dollars invested in Tambocor, 3M moves ahead and seeks approval from the FDA. Other companies also follow suit with similar drugs." "Questions about the safety of Tambocor have already reached the medical review staff at the FDA in Washington, D.C., where a behind-the-scenes drama takes place. 3M presses for approval of Tambocor, while the FDA staff tries to interpret the meaning of reports that some patients who have taken the drug suddenly drop dead. Without a green light from the FDA, Tambocor may be doomed." "The final chapters in the story unfold as 3M gets to the marketplace and, using all the skills of a modern pharmaceutical manufacturer, persuades doctors to use Tambocor. At the same time, an important clinical trial begins. The National Institutes of Health launch an experiment with more than a thousand patients to measure the benefits of Tambocor and two similar drugs. The shocking results of that study and the response of the doctors and companies who promoted these drugs bring the tragedy to a powerful conclusion." "Deadly Medicine is a human story about the brilliant and driven doctors who worked on Tambocor and similar heart drugs - at pharmaceutical companies, within the FDA, and at university medical research centers. It provides a vivid and disturbing account of the system by which drugs are discovered, tested, and marketed to doctors. Through the tragic story of how tens of thousands of patients died prematurely from one class of heart drugs, Deadly Medicine also exposes major flaws in this system."--BOOK JACKET.Title Summary field provided by Blackwell North America, Inc. All Rights Reserved
➤